Phyto-phospholipid
Complex Vesicles:A Revolutionary Approach for Enhancing Bioavailability and
Optimizing Therapeutic Potential in Herbal Medicine
Ruchika
Chandrakar1, Amber Vyas2, Narendra Kumar3,
Umakant Sahu4, Vishal Jain5*
1,2,3,4,5University
Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G),
India-492010
Abstract:
The medicinal potential of phytoconstituents obtained from plants is
widely recognized. Whole-plant extracts or isolated phytoconstituents have been
shown through experiments to exhibit a variety of medicinal potentials,
including antibacterial, neurologically protective, liver-protective
properties, an antioxidant and skin-protective properties. Although these
phytoconstituents offer potential therapeutic effects, their usage is
restricted due to inadequate bioavailability, persistence in physiological fluids,
and authenticity problems. These remain unresolved issues that impact the use
of these priceless traditional herbal remedies in the efficient management and
treatment of a range of medical ailments. Phytoconstituents’ loading in
phospholipid-based vesicular systems may be a way to tackle these challenging
issues. The
goal of this review is to summarize phyto-phospholipid vesicles and some of
their relevant uses in drug delivery systems, as well as to emphasize the
relationship between properties and applications, as well as the effect of
phospholipid species on drug delivery efficiency. Based on the findings of
various research investigations, this literature review attempts to investigate
why Phyto-phospholipid vesicles are considered as the best nanotechnology in
delivery systems for drugs. Optimal
absorption and utilization of nutraceuticals and herbal medications can be
enhanced by the process of Phyto phospholipid complexation.
Keywords: Phyto-phospholipid complexation, Vesicles, Drug
delivery system, Herbal drug, Bioavailability, Therapeutic effects.
Introduction
Phyto-phospholipid
phytovesicles, commonly known as phyto-phospholipid complex vesicles, are a
novel drug delivery system that enhances the bioavailability of plant-derived
bioactive compounds. Indena (Milan, Italy) created
the first Phytovesicles in the late 1980s to improve medicine bioavailability
by combining them with phospholipid (Mandeep and Gagandeep n.d.).
They are formed by complexing natural phospholipids, such as
phosphatidylcholine, with phytoconstituents, leading to the formation of
lipid-compatible molecular complexes. These are plant-derived compounds, often
with potent health benefits, but their clinical efficacy can be limited by poor
absorption and rapid elimination from the body (Bhogam et al. 2023).
Phyto-phospholipid complex vesicles technology addresses these challenges by
creating a lipid-compatible molecular complex, improving the bioavailability
and therapeutic potential of these compounds.
Phyto-phospholipid
phytovesicles are designed to improve the delivery and efficacy of botanical
extracts. By embedding phytoconstituents within a phospholipid bilayer, these
vesicles facilitate better integration with cell membranes, enhancing the
absorption and stability of the active compounds (Dutt et al. 2023). The
phospholipid typically used in phyto phospholipid vesicles formulations is
Phosphatidylcholine, Phosphatidylethanolamine (PE), Phosphatidylinositol (PI),
Phosphatidylserine (PS), and others. This technology addresses common
challenges associated with plant-based therapeutics, such as poor solubility
and low bioavailability, making phytophospholipid complex vesicles a valuable
tool in the fields of pharmaceuticals and nutraceuticals. Through this
approach, the therapeutic potential of plant-derived compounds can be
maximized, leading to more effective treatments and health supplements (Singh et al. 2011). (Table N0. 01 and 02)
Mechanism
of phytophospholipid complex vesicles
Phyto-phospholipid
complex vesicles are formed by complexing phytoconstituents with phospholipids.
This complexation enhances the solubility and absorption of the
phytoconstituents. Phosphatidylcholine, a major component of cell membranes, is
commonly used in phyto-phospholipid complex vesicles formulations. The
phytoconstituent-phospholipid complex mimics the molecular environment of cell
membranes, facilitating easier passage into the bloodstream and enhancing
systemic bioavailability (Sawant and Yadav 2020).
Background and significance’s
Phytochemicals,
the bioactive compounds derived from plants, have long been recognized for
their significant health benefits and therapeutic properties. These compounds,
found in herbs, fruits, vegetables, and other plants, have been used in
traditional medicine for centuries (Dodle et al. 2023). Modern scientific research continues to validate the efficacy of
phytochemicals in preventing and treating various health conditions, including
chronic diseases like cancer, cardiovascular diseases, and neurodegenerative
disorders. However, despite their potential, the clinical application of many
phytochemicals is often limited by poor bioavailability. This refers to the
extent and rate at which the active ingredients are absorbed and become
available at the site of action (Dodle et al. 2023).
The
bioavailability of phytochemicals is typically hampered by several factors,
including poor solubility in water, instability in the digestive tract, rapid
metabolism, and elimination from the body. These limitations can result in
insufficient therapeutic concentrations of the active compounds in the
bloodstream, reducing their efficacy (Poudyal et al. 2022). Therefore, there is a growing need for innovative delivery systems
that can enhance the absorption and bioavailability of these beneficial
compounds.
Method
of preparations of complex vesicles
To create a drug-phosphatidylcholine complex, an equimolar concentration
of drug was combined with phosphatidylcholine. Equimolar drug concentrations
were combined in a 100 ml round bottom flask with 25 ml dichloromethane for 3
hours in a closed conical flask. To precipitate the complex, add 30 ml of
phosphate buffer to the solution at a concentration of 10-15 ml, or 1/3 of the
volume, and then filter. Additionally, it can be used to make phyto-phospholipid
complex vesicles (Gaurav et al. 2021). (Figure 01 and 02)
v Solvent Evaporation thin film hydration technique of phyto-phospholipid
complex vesicles
·
This method involves dissolving
both the phytoconstituent and phospholipid in a suitable aprotic solvent,
followed by solvent evaporation to form a thin film containing the
phyto-phospholipid complex vesicles.
·
Dissolve 10 mg of the
phytoconstituent and equimolar ratio of the phospholipid in 20 ml of the
organic solvent, Transfer the solution to a round-bottom flask. Attach the
flask to a rotary evaporator.
·
Set the water bath temperature
of the rotary evaporator to 40-60°C (choose a temperature that ensures solvent
evaporation without degrading the phytoconstituent).
·
Evaporate the solvent under
reduced pressure until a thin film is formed on the inner walls of the round
bottom flask.
·
Further dry the thin film under
vacuum in a desiccator to remove any residual solvent. Drying time typically
12-24 hours, depending on the solvent and conditions.
·
Hydrate the thin film with a
small amount of water or buffer to form a suspension if a liquid formulation is
desired.
·
Sonicate the suspension if
necessary to reduce particle size. keep the temperature below 30°C during
sonication to prevent degradation.
·
Store the resultant
phyto-phospholipid complex vesicles complex in an airtight container,
preferably under refrigerated conditions to maintain stability(Saputra, Dzakwan, and Dewi 2020).
v Thin
film formation technique of phyto-phospholipid complex vesicles complex
·
Weigh out the phytoconstituent
and phospholipid. Dissolve both in a mixture of organic solventsin a 2:1
ratio).
·
Transfer the solution to a
round-bottom flask; attach the flask to a rotary evaporator.
·
Evaporate the solvent under
reduced pressure to form a thin film on the inner wall of the flask, set the
rotary evaporator to operate at a temperature of 40-60°C.
·
Rotate at 150-200 rpm for
efficient solvent removal (Gaikwad et al. 2021).
·
Once the solvent has
evaporated and a thin film is formed, remove the flask from the evaporator.
·
Add a hydration medium (e.g.,
water or a suitable buffer) to the flask to hydrate the thin film.
·
Typical hydration volume: 10
mL for the given amount of phytoconstituent and phospholipid maintain the
hydration temperature at 25-40°C, Swirl or gently shake the flask to ensure
even hydration of the film.
·
Sonicate the hydrated mixture
using a bath sonicator or probe sonicator to reduce the size of phyto-phospholipid
complex vesicles and ensure homogeneity, Keep the temperature
below 30°C during sonication to prevent degradation of the phytoconstituent.
·
After hydration and
sonication, a uniform suspension of phyto-phospholipid complex vesicles
is formed.
·
Collect the phyto-phospholipid
complex vesicles suspension, If a dry phyto-phospholipid
complex vesicles powder is desired, further process the
suspension. Freeze-dry or vacuum-dry the suspension to obtain the phyto-phospholipid
complex vesicles complex in powder form.
·
Store the prepared phyto-phospholipid
complex vesicles in an airtight amber container,Protect from
light and moisture and store at a cool temperature (preferably 4-8°C) (Saputra, Dzakwan, and Dewi 2020).
v Reflux technique of phyto-phospholipid complex vesicles complexation
- Measure the desired
quantities of phytoconstituent and phospholipid according to the desired
ratio. Typical ratios range from 1:1 to 1:2 (phytoconstituent), but this
can vary depending on the specific compounds and desired properties.
- Dissolve the
phytoconstituent and phospholipid in anaprotic solvent in a round-bottom
flask. The volume of the solvent can vary based on the solubility of the
compounds.
- Set up the reflux
apparatus with a condenser attached to the round-bottom flask containing
the solution.
- Heat the solution under
reflux conditions, typically at the 40°Cor
slightly higher for 3 hours. Refluxing allows for thorough mixing and
incorporation of the phytoconstituent into the phospholipid bilayer.
- After the reflux period,
allow the solution to cool to room temperature.If necessary, isolate the phyto-phospholipid
complex vesicles complex by evaporating
off the solvent under reduced pressure or by other means such as
filtration or centrifugation.
- Dry the isolated phyto-phospholipid
complex vesicles complex under vacuum or
by other suitable methods such as freeze-drying (lyophilization).
- Store
the dried phyto-phospholipid complex vesicles complex in a amber colour container under appropriate conditions to
prevent degradation. (R. P. Singh, Gangadharappa, and Mruthunjaya 2018)
v Cosolvent technique of phyto-phospholipid complex vesicles complexation
- Dissolve the
phytoconstituent and phospholipid in a suitable solvent. Add a
predetermined amount of cosolvent (glycerol,
propylene glycol) to the solvent mixture.
- Typical cosolvent ratio:
10-50% (v/v) of the total solvent volume, Example: Add 1-5 mL of cosolvent
to 10 mL of solvent mixture.
- Stir the solution to
ensure uniform mixing. Optionally, perform sonication to further enhance
solubility and mixing.
- Evaporate the solvent
mixture using a rotary evaporator under reduced pressure.
- Further dry the residue
under vacuum to remove any residual solvent.
- Store the resultant
complex in an airtight container (Vaishnavi et al. 2021).
v Antisolvent
precipitation technique
· Dissolve
the phytoconstituent and phospholipid in a suitable organic solvent, Typical
ratio: 1:1. For example: 100 mg of each in 10 mL of ethanol.
· Add the
solution dropwise to water (anti-solvent) with constant stirring. At room
temperature to 25°C.
· Volume
of anti-solvent: 100 mL (10 times the solvent volume).
· Collect
the precipitated phyto-phospholipid complex vesicles by filtration or
centrifugation, Centrifuge at 4°C if needed (Rani, Kumar, and Khar 2022).
v Mechanical dispersion technique of phyto-phospholipid
complex vesicles complexation
·
The mechanical dispersion method is a
technique used for the preparation of phyto-phospholipid complex vesicles,
where the active phytoconstituents are dispersed in a phospholipid solution
under mechanical agitation. Here's a simplified procedure along with typical
ratios:
·
Dissolve the phytoconstituent
and phospholipid in an organic solvent. Typical ratio: 1:1 or as desired. Mix
the solution thoroughly to ensure uniform dispersion.
·
Use a mechanical disruptor
such as a homogenizer, ultrasonicator or magnetic stirrer.
·
Apply mechanical force to
disrupt the lipid bilayers and disperse the phytoconstituents within the
phospholipid matrix.
·
Duration and intensity of
homogenization can vary depending on the equipment used and the desired
particle size. typically at room temperature or below to avoid degradation of
sensitive components (Zhang et al. 2018).
·
If necessary, remove the
solvent under reduced pressure or by evaporation.
·
If residual solvent is present
after removal, further dry the phyto-phospholipid complex vesicle dispersion
under vacuum or by gentle heating. Mild heating up to 40-50°C can be applied if
necessary.
Advantages
of Phytosomes
§ Enhanced
Bioavailability: One of the main advantages of Phyto-phospholipid
complex vesicles complexes is their ability to improve the bioavailability of
herbal active constituents. Phyto-phospholipid complex vesicles can
encapsulate poorly soluble phytochemicals, such as flavonoids, terpenoids, and
polyphenols, within phospholipid bilayers(Nanavati 2017). This
enhances their solubility and absorption in the gastrointestinal tract, and
outer surface of body leading to higher plasma levels of the active compounds.
§ Stability
Enhancement: Phyto-phospholipid complex vesicles technology can improve the stability of
herbal extracts by protecting them from degradation, oxidation, or other
chemical reactions. This ensures the preservation of the therapeutic properties
of the active compounds over time (Telange et al. 2017).
§ Standardization
of Herbal Extracts: Phyto-phospholipid complex vesicles
technology enables the standardization of herbal extracts based on their
bioactive content rather than just their raw plant material. By encapsulating
specific phytochemicals within Phytophospholipid complex vesicles complexes (Molaveisi,
Shahidi,Noghabi and Naji Tabasi 2020).
§ Targeted
Drug Delivery: Phytophospholipid complex vesicles can be designed to
facilitate targeted drug delivery to specific tissues or organs within the
body. By modifying the surface properties of Phyto-phospholipid complex
vesicles complexes or incorporating targeting ligands, herbal active
constituents can be delivered selectively to sites of action, minimizing
off-target effects and improving therapeutic outcomes (Shriram et al.
2022).
§ Combination
Therapy: Phyto-phospholipid
complex vesicles technology allows for the formulation of combination therapies
where multiple herbal active constituents or conventional drugs are
co-encapsulated within Phyto-phospholipid complex vesicles complexes. This
synergistic approach can enhance the therapeutic efficacy by targeting multiple
pathways involved in disease pathogenesis or by potentiating the effects of
individual components (Chen et al. 2024).
§ Clinical
Applications: Phyto-phospholipid complex vesicles formulations have
been investigated and utilized in the treatment of various health conditions,
including liver disorders, cardiovascular diseases, metabolic syndrome,
inflammation, and oxidative stress-related disorders.
§ Improved
Bioavailability: Phyto-phospholipid complexation
significantly enhance the absorption of phytoconstituents compared to
conventional herbal extracts. Studies have shown increased plasma levels of
active compounds, leading to improved efficacy.
§ Enhanced
Therapeutic Effects: With better absorption, the therapeutic
effects of phytochemicals are more pronounced. This can lead to lower required
doses and reduced side effects.
§ Sustained
Release: Phyto-phospholipid
complexation formulations can provide a controlled release of the active
compounds, maintaining therapeutic levels in the blood over an extended period (Palachai et al. 2020).
§ Better
Stability:
The complexation with phospholipids can protect phytochemicals from degradation
by digestive enzymes and harsh pH conditions in the gastrointestinal tract.
§ Enhanced
Skin Penetration: Phyto-phospholipid complex vesicles
complexes improve the skin penetration of herbal active constituents by
encapsulating them within phospholipid bilayers. This enhanced penetration
allows the bioactive compounds to reach deeper layers of the skin where
inflammation may be localized (Allaw et al. 2022).
§ Reduced
Irritation: Transdermal delivery of herbal extracts can sometimes
cause skin irritation. Phyto-phospholipid complex vesicles complexes help
mitigate this issue by encapsulating the active constituents, thereby reducing
direct contact with the skin surface and minimizing irritation while
maintaining therapeutic efficacy (Allaw et al. 2022).
§ Weight
Management: Certain plant extracts, when complexed with
phospholipids in phytosomes, may assist in weight management by enhancing the
absorption of bioactive compounds that promote fat metabolism and appetite
control.
§ Nutraceuticals: Phyto-phospholipid complex vesicles
are utilized in the development of
nutraceutical products, where they enhance the bioavailability of
phytochemicals present in dietary supplements. This improves the effectiveness
of the supplements in delivering health benefits (El-Menshawe
et al. 2018).
§ Formulation
Flexibility: Phyto-phospholipid
complex vesicles offer flexibility
in formulation design, allowing for the development of various dosage forms
such as tablets, capsules, liquid formulations, and topical preparations.
§ Cosmaceuticals: Phyto-phospholipid complex vesicles
technology is also employed in the
formulation of cosmeceutical products, such as skincare creams and serums. By
increasing the absorption of herbal extracts, it enhances the skin's ability to
utilize the active ingredients for various skincare benefits(Hendawy et al. 2023).(Table No. 03 and 04)
Future
Perspectives and Conclusion
In
conclusion, phyto-phospholipid complex vesicles offer a promising approach to
enhance the bioavailability, efficacy, and targeted delivery of
phytoconstituents in clinical applications. Clinical evidence supports their
ability to improve absorption, enhance therapeutic effects, and provide
targeted delivery to specific tissues or organs. Phyto-phospholipid complex
vesicles formulations have demonstrated efficacy in managing various health
conditions, including chronic diseases, metabolic disorders, inflammatory
conditions, and skin health. Furthermore, their favourable safety profile and
tolerability make them attractive candidates for long-term use. However,
further research is warranted to fully understand their mechanisms of action,
optimize formulations, and explore their potential applications in diverse
clinical settings. Overall, phyto-phospholipid complex vesicles represent a
valuable strategy to harness the therapeutic potential of plant-based compounds
for improved health outcomes. Phyto-phospholipid complex vesicles technology
represents a significant advancement in the delivery of phytochemicals,
overcoming traditional barriers of poor absorption and rapid metabolism. By
enhancing the bioavailability and therapeutic efficacy of plant-based
compounds, phytophospholipid complex vesicles hold great promise in the
development of more effective and safer herbal medicines. As research
progresses, we can expect to see more innovative applications and formulations,
further expanding the potential of this revolutionary drug delivery system.
References:
Agarwal, A., Wahajuddin, M., Chaturvedi, S.,
Singh, S. K., Rashid, M., Garg, R Chauhan,
D; Sultana,
N.,
Gayen, J. R. (2024). Formulation and Characterization of Phytosomes as Drug
Delivery System of Formononetin: An Effective Anti-Osteoporotic
Agent. Current Drug Delivery, 21(2): 261-270.
Allaw, M., Manca,
M. L., Castangia, I. and Manconi, M. (2022). From plants to phospholipid
vesicles: A comprehensive review on the incorporation of phytochemicals into
phospholipid vesicles designed for skin applications with special focus on
scalability and in vitro and in vivo efficacy. Journal of Drug Delivery
Science and Technology, 67: 103049.
Amjadi, S., Shahnaz, F.,
Shokouhi, B.,
Azarmi, Y., Siahi-Shadbad, M., Ghanbarzadeh, S., ... & Hamishehkar, H.
(2021). Nanophytosomes for enhancement of rutin efficacy in oral administration
for diabetes treatment in streptozotocin-induced diabetic
rats. International journal of pharmaceutics, 610: 121208..
Andishmand, H., Yousefi, M., Jafari, N.,
Azadmard-Damirchi, S., Homayouni-Rad, A., Torbati, M. and Hamishehkar, H. (2024). Designing and
fabrication of colloidal nano-phytosomes with gamma-oryzanol and phosphatidylcholine
for encapsulation and delivery of polyphenol-rich extract from pomegranate
peel. International Journal of Biological Macromolecules, 256:
128501.
List of Figures

Figure No. 1: Schematic Representation of Preparation of Complex of
Phytophospholipid complex vescicle

Figure No. 2: preparation of
Phytophospholipid complex vesicles with hand shaking method
List of
Tables
Table No.
01 - Materials Used for phytophospholipid Complex formulation (Pierro
et al. 2021, Poudyal
et al. 2022, Pasala et
al. 2022)
|
S. No.
|
Category
|
Examples
|
Uses
|
|
1.
|
Drugs
|
Herbal drugs,
Polyphenols, Flavonoid, Terpenoids etc
|
Phytoconstituents
|
|
2.
|
Phospholipid
|
Soya lecithin
Egg
phosphatidylcholine
Soya-Phosphatidylcholine
Distearyl
phosphatidylcholine
Dipalmitoyl
phosphatidylcholine
|
Vesicle
Forming compound
|
|
3.
|
Aprotic
solvents
|
Aceton, Diethyl
ether, Dioxane, Methylene chloride As a Solvent
|
As
a solvent
|
|
4.
|
Organic
solvent
|
Chloroform
|
For
preparing thin film
|
|
5.
|
Non
solvent
|
n-hexane,
aliphatic hydrocarbons
|
Complex
precipitation solvent
|
|
6.
|
Buffering
agent
|
Saline phosphate
buffer (pH 4-7)
Ethanol 7% v/v
Tris buffer pH
4-7
|
Hydration
solvent
|
Table No. 02. System for characterization of Phytophospholipid vesicles
parameter (El-Batal et
al. 2018, Agarwal et
al. 2024)
|
S. No.
|
Parameter
|
Methods
|
|
1.
|
Style
vesicle shape (Morphology)
|
Transmission
electron microscopy
|
|
2.
|
Entrapment
efficacy
|
Mini
column centrifugation system
|
|
3.
|
Vesicle
size and size distribution
|
Dynamic
light scattering system
|
|
4.
|
Surface
charge and charge density
|
Zeta
sizer/metres
|
|
5.
|
Skin
saturation implicit
|
Luminescence
microscopy
Transmission
electron microscope
Thin
layer chromatography
|
|
6.
|
In
vitro drug release studies
|
Dialysis
bag diffusion
Side
by side diffusion cell with natural or artificial membrane’s
|
|
7.
|
Stability
studies
|
Dynamic
light scattering system
Transmission
electron microscopy
|
Table
No. 03. An overview of current research on phytophospholipid complex vesicles,
methods of preparations used, solvents used, and values.
|
S.No.
|
Various
Phytophospholipid complexes
|
Technique
used
|
Used
solvents
|
Reference
|
|
8.
|
Nanophytosomes
with rutin inside
|
Solvent evaporation technique,thin layer hydration method
|
Methanol and chloroform (1:4).
|
(Amjadi et al. 2021)
|
|
9.
|
Berberine and phospholipid complexation
|
Solvent evaporation phytosome preparation technique.
|
Hot ethanol
|
(Rondanelli et al. 2023)
|
|
10.
|
Phospholipid
and luteolin complex
|
Quality by Design for solvent evaporation
|
Ethanol
|
(Hindarto et al. 2017)
|
|
11.
|
Methanolic
extract (TBE) combined with phytosomes of Terminalia Arjuna
|
Salting out Method
|
Methylene chloride and methanol (6:1) n-hexane
|
(DWIVEDI et al. 2023)
|
|
12.
|
Phytosomes
Containing Naringenin-Loaded Dipalmitoyl PC
|
Solvent
evaporation method
|
Methanol,
ethanol, and ethyl acetate
|
(Priya and Kumaran 2023)
|
|
13.
|
Phospholipids
and rosmarinicacid (RA) complex
|
Solvent evaporation
|
Anhydrous ethanol
|
(Priya and Kumaran 2023)
|
|
14.
|
Centrella
extract complex on phospholipids
|
Salting out Method
|
n-hexane, Ethanol
|
(Tripathy and Srivastav 2023)
|
|
15.
|
Phyllanthusemblica
extract complex with phospholipid
|
Solvent evaporation method
|
Dichloromethane or methanol as solvent
|
(Ridwan, Hartati, and Pamudji 2023)
|
|
16.
|
Aloe-vera extracted phytosome loaded gel
|
Thin
layer hydration technique
|
Chloroform
|
(Joshua et al. 2018)
|
|
17.
|
oleanolic
acid with complexation of
phospholipid
|
Solvent evaporation method with 1:1 molar ratio
|
Anhydrous ethanol
|
(Wang et al. 2020)
|
|
18.
|
echinacoside
complex with
phospholipids
|
Solvent
evaporation method with 1:3 molar ratio
|
Tetrahydrofuran
|
(Rani, Kumar, and Khar 2022)
|
|
19.
|
Apigenin
and phospholipid-containing phytosome, the Phospolipon® 90H Solvent
|
Solvent evaporation method
|
1-4 dioxane, methanol
|
(Telange et al. 2017)
|
|
20.
|
epigallocatechin
complexed with gallate and phospholipid
|
Solvent
Evaporation method
|
Ethanol
|
(Shriram et al. 2022)
|
|
21.
|
Extract-phospholipid
of pomegranates
|
Spray
drying
|
Equal
volumes of dioxane and methanol,
|
(Andishmand et al. 2024)
|
|
22.
|
silymarin
with phospholipid complexation
|
Solvent
evaporation method with 1:5 molar ratio
|
Ethanol
|
(Pasala et al. 2022)
|
|
23.
|
Phytosome-loaded
complex of gingerol soya Lecithin
|
Anti-solvent
precipitation technique
|
Methanol
|
(R. P. Singh, Gangadharappa, and Mruthunjaya 2018)
|
|
24.
|
Polyphenol-Based
Phytosome Derived from Moringa Oleifera Leaf Tofu PC
|
Thin-layer hydration
|
Ethanol, Dichloromethane
|
(Rani, Kumar, and Khar 2022)
|
|
25.
|
Phospholipid
and curcumin Phytosome
|
Solvent evaporation method
|
Dichloromethane
|
(Agarwal et al. 2024)
|
|
26.
|
Complexation
of soybean phosphatidyl choline and mitomycin C
|
Solvent evaporation method
|
Distilled water
|
(El-Menshawe et al. 2018)
|
|
27.
|
Piper longum Phytosome
|
Solvent evaporation method
|
Aprotic solvent
|
(Islam et al. 2022)
|
Table No. 04. Commercialized phytophospholipid complex vesicles
with Phytochemicals.
|
S. No.
|
Parts of herbs used
|
Commercialized phytosomes
|
Phytoconstituents
|
Applications
|
Reference
|
|
1.
|
Silybiummaranium(Milk Thistle)
|
Silybin PhytosomeTM
(Siliphos®)
|
Silybin,
isosilbin,
silydianin, and
silycristin
|
Inflammation,
cirrhosis,
hepatitis, and
hepatoprotective.
|
(Poltavets et al. 2021)
|
|
2.
|
Gingko biloba
(Maiden hair tree)
|
GingkoselectPhytosomeTM
|
Ginkgoic acids of ginkgolides, and bilobalide,flavonoids from ginkgo,
ginkgolides and bilobalide
|
Anti-aging,
anti-asthmatic,
anti-amnestic,
antidepressant
cardioprotective
anti-inflammatory.
|
(Sawant and Yadav 2020)
|
|
3.
|
Olea europaea
(Olive tree)
|
OleaselectPhytosomeTM
|
Verbascoside, hydroxytyroso l, and tyrosol.
|
Antioxidant,
anticancer,
anti-inflammatory, antihyperlipidemic.
|
(Mahmood et al.
2023)
|
|
4.
|
Panax ginseng (Ginseng)
|
Ginseng PhytosomeTM
|
Ginsenosides
|
Supplements,
immunomodulators.
|
(Nanavati 2017)
|
|
5.
|
Camellia sinensis (Tea)
|
Green tea PhytosomeTM
|
Epigallocatechin,
epigallocatechin-3-O-gallate,
catechin, and epigallocatechin.
|
Nutraceutical,
antioxidant,
anti-cancer
Hepatoprotective,
Atherosclerosis,
Anticancer,
decreases weight,
Antidiabetic,
Anti-inflammatory.
|
(Myneni, Radha,
and Soujanya 2021)
|
|
6.
|
Vaccinium angustifolium
(Blue berry)
|
VitaBluePhytosomeTM
|
Alpha-lipoic acid,
tocotrienol complex from
anthocyanosises, and
bioflavonoids from citrus
|
Memory booster,
antioxidant,
vision improvement.
|
(Martins-Gomes, Souto, and Silva 2022)
|
|
7.
|
Curcuma longa
(Turmeric)
|
Curcumin PhytosomeTM
Curcuvet®
(Meriva®)
|
Curcumin
|
Osteoarthritis,
cancer,
antibiotic
anti-inflammatory
|
(Mirhafez et al.
2021)
|
|
8.
|
Vitis vinifera (Grapes)
|
Biovin and leucoselect
PhytosomeTM
|
Procyanidins,
epicatechins,
resveratrol,
and quercetin
|
Antioxidant systemic,
nutraceutical,
cardioprotective.
|
(Surini, Mubarak,
and Ramadon 2018)
|
|
9.
|
Panicum miliaceum
(Millet)
|
Millet PhytosomeTM
|
Amino acids,
minerals,
unsaturated
fatty acids,
vitamins
|
foods that are anti-stress and
healthy for hair, nails, and skin.
|
(Priya and Kumaran 2023)
|
|
10.
|
Ruscus aculeatus
(Butchers broom)
|
Ruscogenin PhytosomeTM
|
Ruscogenin, neoruscogenin
|
Sunblock agent,
antiaging,
antiinflammation
|
(Thomas and Mukassabi 2014)
|
|
11.
|
Terminali a serica
(Silver clusterleaf)
|
Sericoside
PhytosomeTM
|
Sericoside
|
Skin remodelling,
wound healing, antioedema
anti-inflammatory properties
|
(DWIVEDI et al. 2023)
|
|
12.
|
Centella asiatica (Brahmi)
|
Centella triterpenoid
PhytosomeTM
|
Madecassic acid, or Asiatic acid.
|
Skin conditions,
ulcer prevention,
wound healing, and
anti-hair loss medication
|
(DWIVEDI et al. 2023)
|
|
13.
|
Citrus aurantium (Bitter orange)
|
Naringenin PhytosomeTM
|
Naringenin.
|
Antioxidant
|
(A. Singh et al. 2011)
|
|
14.
|
Santalum album
(Sandal wood)
|
Ximilene and
Ximenoil
PhytosomeTM
|
Ximenynic acid,
ethyl ximenynate
|
Improves microcirculation
|
(Krishnakumar, Parthiban, and Kanna 2017)
|
|
15.
|
Zanthoxylum
bungeanum
(Tumburu)
|
Zanthalene
PhytosomeTM
|
Hydroxy-a-sanshool
|
Anti-reddening and
calming
|
(Kumar, Baldi,
and Sharma 2019)
|
|
16.
|
Glycine max (Soy)
|
SoyselectPhytosomeTM
|
Genistein
and daidzein
|
Anticarcinogenic;
antiangiogenic;
|
(Kim et al. 2020)
|
|
17.
|
Syzygiumcumini
(Jamun)
|
Madeglucyl
PhytosomeTM
|
Tannins
|
Anti-inflammatory,
Antihyperglycemic,
antioxidant
|
(Gupta et al.
2022)
|
|
18.
|
Pinus maritima
(Pine)
|
Pycnogenol
PhytosomeTM
|
Procyanidins
|
Anti-inflammatory,
anti-aging,
anti-allergenic
|
(Gupta et al. 2022)
|
|
|
|
|
|
|
|